<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-11-21T03:33:30Z</responseDate><request verb="GetRecord" identifier="oai:macsphere.mcmaster.ca:11375/23864" metadataPrefix="dim">https://prod-ms-be.lib.mcmaster.ca/server/oai/request</request><GetRecord><record><header><identifier>oai:macsphere.mcmaster.ca:11375/23864</identifier><datestamp>2026-09-24T21:01:35Z</datestamp><setSpec>com_11375_271</setSpec><setSpec>col_11375_272</setSpec></header><metadata><dim:dim xmlns:dim="http://www.dspace.org/xmlns/dspace/dim" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.dspace.org/xmlns/dspace/dim http://www.dspace.org/schema/dim.xsd">
   <dim:field mdschema="dc" element="contributor" qualifier="advisor">Mahony, James</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="author">Bulir, David</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="department" lang="en_US">Medical Sciences</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="accessioned">2019-02-05T21:01:21Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="available">2019-02-05T21:01:21Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="issued">2018</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="uri">http://hdl.handle.net/11375/23864</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="uri">https://doi.org/10.71548/13561</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="abstract" lang="en_US">Chlamydiae spp. are a significant cause of disease worldwide. Chlamydia&#xd;
pneumoniae is a respiratory pathogen which is believed to cause approximately&#xd;
10% of community-acquired pneumoniae. Furthermore, C. pneumoniae infections&#xd;
have been associated with the development of atherosclerosis, exacerbation of&#xd;
asthma, multiple sclerosis and Alzheimer’s. Chlamydia trachomatis, the causative&#xd;
agent of trachoma, is responsible for over 6 million cases of preventable&#xd;
blindness each year. Furthermore, C. trachomatis is the leading bacterial sexually&#xd;
transmitted infection in North America. Yet, given how prevalent chlamydial&#xd;
infections are, there is still limited information regarding the pathogenic&#xd;
mechanisms by which Chlamydia infects its host.&#xd;
Type III secretion is a conserved pathogenic virulence factor used by&#xd;
gram-negative bacteria. Type III secretion has been extensively studied in other&#xd;
bacterial genera, but given the difficulty of working with Chlamydia, there have&#xd;
been few advances in our understanding of the role of type III secretion in&#xd;
chlamydial pathogenesis. A set of proteins, called translocators, are believed to&#xd;
be indispensable for infection; however, a comprehensive biochemical&#xd;
characterization of them has not been undertaken. Using GST-pulldown assays,&#xd;
interactions between Chlamydia outer protein (Cop) B and D from C. pneumoniae&#xd;
and other components of the type III secretion system are characterized.&#xd;
Furthermore, site-directed mutagenesis was used to elucidate the critical amino&#xd;
acids involved in interaction between the putative chaperone, LcrH_1, and both CopB and CopD. We also demonstrate that CopD is capable of forming higher&#xd;
ordered structures, and that CopD and LcrH_1 interact in a 1:1 ratio. Using&#xd;
polyclonal antibodies directed towards the translocator proteins, we demonstrate&#xd;
that CopB and CopD may be surface exposed prior to host cell contact and&#xd;
critical to infection. A synthetic peptide consisting of the chaperone binding&#xd;
domain was capable of blocking the interaction between LcrH_1 and the&#xd;
translocator proteins, as well as inhibiting infection in vitro. Lastly, an animal&#xd;
model of Chlamydia infection was developed to explore whether the use of type&#xd;
III secretion system proteins could be used to protect against Chlamydia infection&#xd;
and Chlamydia induced pathology.</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="degreetype" lang="en_US">Thesis</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="degree" lang="en_US">Doctor of Philosophy (PhD)</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="layabstract" lang="en_US">Chlamydia species are gram-negative bacteria that cause a wide range of&#xd;
human disease, including pneumonia, blinding trachoma, and sexually&#xd;
transmitted infections. However, our current understanding of the mechanisms by&#xd;
which Chlamydiae infects its host is relatively unknown. Using various&#xd;
biochemical techniques, the function of two proteins that are believed to be&#xd;
important for chlamydial pathogenesis are explored. Using an animal model for&#xd;
chlamydial genital infections, a novel vaccine was developed to evaluate its&#xd;
ability to protect against a live Chlamydia challenge and reduce the prevalence of&#xd;
sequelae.</dim:field>
   <dim:field mdschema="dc" element="language" qualifier="iso" lang="en_US">en</dim:field>
   <dim:field mdschema="dc" element="title" lang="en_US">Characterization of the chlamydial type III secretion translocator proteins CopB and  CopD</dim:field>
   <dim:field mdschema="dc" element="title" qualifier="alternative" lang="en_US">Characterization of the chlamydial T3S translocator proteins</dim:field>
   <dim:field mdschema="dc" element="type" lang="en_US">Thesis</dim:field>
   <dim:field mdschema="others" element="access-status">open.access</dim:field>
</dim:dim></metadata></record></GetRecord></OAI-PMH>